FDA Grants Breakthrough Therapy Designation to VERTANICAL’s VER-01 for Chronic Low Back Pain
The FDA breakthrough therapy chronic low back pain designation for VER-01 marks a key regulatory milestone. This cannabis-derived treatment targets a widespread condition with high opioid reliance. VER-01's expedited development could offer a safer,…
Luke O’Neill: More reasons to exercise — from a beefier brain to a cannabis-like high
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyAgingMental HealthAnxietyPainSafety Why This Matters Exercise triggers endocannabinoid release in the…
Researchers Identify Genetic Pathways Linking Cannabis Use Disorder and Psychosis Risk
✦ New CED Clinical Relevance #68 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMental HealthTHCNeurologySafetyPolicyAnxiety Why This Matters # Clinicians need to understand these genetic…
Does Smoking Weed Cause Erectile Dysfunction? What the Evidence Shows for Men …
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchSafetyTHCAnxietyMental HealthNeurologyCBD Why This Matters Clinicians need evidence-based information about…
Researchers Can Now Study State-Legal Medical Cannabis, But Hurdles Remain
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafetyPainAnxietyMental HealthNeurology Why This Matters Federal rescheduling of cannabis to Schedule…
A 44-year study has found that long-term cannabis use does NOT accelerate cognitive … – Facebook
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchAgingTHCSafetyMental HealthCannabis Clinical Summary A longitudinal study spanning 44 years…
CBD Gummies for Tinnitus: What the Science Says and How to Choose
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDResearchNeurologySafetyDosingMental HealthAnxiety Why This Matters Clinicians need to understand the limited…
Europe’s Medical Marijuana Market Positioned for Explosive Multi-Billion Dollar Growth …
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchIndustryPainAnxietyCancerNeurology Why This Matters Clinicians treating patients in Europe should prepare…
What’s the latest with cannabis and schizophrenia? – Medical News Bulletin
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. NeurologyMental HealthResearchTHCCBDSafetyMedicine Clinical Summary # Cannabis and Schizophrenia: Clinical Summary…
Flower no longer fastest growing item prescribed to UK cannabis patients – leafie
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. PainNeurologyPolicyResearchIndustrySafetyDosing Why This Matters UK clinicians prescribing medical cannabis should be…
